Journal of Korean Biological Nursing Science

Korean society of Biological Nursing Science (한국기초간호학회)
권호 표지
DOI QR코드

DOI QR Code

Current Status of Interval of Heparin Flushing for Maintenance of an Implanted Port in Solid Tumor Patients

고형암 환자의 삽입형 포트 개방성 유지를 위한 헤파린 관류 주기 현황

  • Kim, Hye Kyung (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea) ;
  • Choi, So Eun (Department of Nursing, Mokpo National University) ;
  • Lee, Jung Hoon (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea) ;
  • We, Eun Sook (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea) ;
  • Joh, Hye Jin (Oncology APN, Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea) ;
  • Kim, Kwang Sung (Cancer Center, Seoul St. Mary' Hospital, The Catholic University of Korea)
  • 김혜경 (가톨릭대학교 서울성모병원 종양전문) ;
  • 최소은 (목포대학교 간호학과) ;
  • 이정훈 (가톨릭대학교 서울성모병원 종양전문) ;
  • 위은숙 (가톨릭대학교 서울성모병원 종양전문) ;
  • 조혜진 (가톨릭대학교 서울성모병원 종양전문) ;
  • 김광성 (가톨릭대학교 서울성모병원 암센터/BMT센터)
  • Received : 2014.07.03
  • Accepted : 2014.08.07
  • Published : 2014.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Little is known about appropriate interval periods between the heparin flushing of implanted ports after completion of chemotherapy. The purpose of this study was to describe the current status of interval of heparin flushing for maintenance of an implanted port in solid tumor patients. Methods: We performed a retrospective review of all patients who had undergone implanted port removal in 2012 at the Seoul St. Mary's Hospital. The subjects were 90 patients who, after completion of chemotherapy, retained their ports for extended periods of time. Results: The mean number of flushes of heparin was 4. Compliance with visits for implanted port maintenance varied with the individual, and the mean accession times were in the range between 13 days and 243 days. The overall mean time between flushes was 66 days. One patient showed resistance during flushing. Conclusion: Our results demonstrate that extending the flushing interval to a maximum of 8 weeks remains medically safe. Less frequent heparin flushing of an implanted port decreases medical expenditure and the workload of medical professionals; it also improves the patient's satisfaction.

Keywords

References

  1. Bae, J. I. (2011). Insertion and management of central venous catheter. Hanyang Medical Reviews, 31(1), 23-31. https://doi.org/10.7599/hmr.2011.31.1.23
  2. Baskin, J. L., Pui, C. H., Reiss, U., Wilimas, J. A., Metzger, M. L., Ribeiro, R. C., et al. (2009). Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet, 374(9684), 159-169. https://doi.org/10.1016/S0140-6736(09)60220-8
  3. Camp-Sorrell, D. (2004). Access device guidelines: Recommendations for nursing practice and education (2nd ed). Pittsburgh, PA: Oncology Nursing Society.
  4. Dougherty, L. (2006). Central Venous Access Devices Care and Management. Blackwell Publishing: Oxford.
  5. Eugenia, G., Rebecca, P., Gary, L. G., & Dennis, K. (2013). Extending the interval for port-a-cath maintenance. Modern Chemotherapy, 2(2), 15-18. https://doi.org/10.4236/mc.2013.22003
  6. Green, E., Macartney, G., Zwaal, C., Marchand, P., Kutzscher L., Savage P., et al. (2008). Managing central venous access devices in cancer patients: A practice guideline. Canadian Oncology Nursing Journal, 18(2), 1-9.
  7. Hickman, R. O., Buckner, C. D., Clift, R. A., Sanders, J. E., Stewart, P., & Thomas, E. D. (1979). A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surgery Gynaecology & obstetrics, 148(6), 871-875.
  8. Ignatov, A., Ignatov, T., Taran, A., Smith, B., Costa, S. D., & Bischoff, J. (2010). Interval between port catheter flushing can be extended to four months. Gynecologic and Obstetric Investigation, 70(2), 91-94. https://doi.org/10.1159/000294919
  9. Kefeli, U., Dane, F., Yumuk, P. F., Karamanoglu, A., Iyikesici, S., Basaran, G., et al. (2009). Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. European Journal of Cancer Care, 18(2), 191-194.
  10. Kock, H. J., Pietsch, M., Krause, U., Wilke, H., & Eigler, F. W. (1998). Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World Journal of Surgery, 22(1), 12-16. https://doi.org/10.1007/s002689900342
  11. Korean Oncology Nursing Society. (2009). Oncology nursing practice guideline. Asian Oncology Nursing, 9(1), 76-115.
  12. Kuo, Y. S., Schwartz, B., Santiago, J., Anderson, P. S., Fields, A. L., & Goldberg, G. L. (2005). How often should a port-A-cath be flushed? Cancer Investigation, 23(7), 582-585. https://doi.org/10.1080/07357900500276923
  13. Lamont, J. P., McCarty, T. M., Stephens, J. S., Smith, B. A., Carlo, J., Livingston, S. et al. (2003). A randomized trial of valved vs nonvalved implantable ports for vascular access. Baylor University Medical Center Proceeding, 16(4), 384-387. https://doi.org/10.1080/08998280.2003.11927932
  14. Lersch, C., Kotowa, W., Fung, S., & Janssen, D. (2004). Prophylaxis of port system-associated thrombosis in advanced oncology patients using heparin flushing. Journal of Cancer Research and Clinical Oncology, 130(40), 235-241. https://doi.org/10.1007/s00432-003-0528-5
  15. Maki, D. G., Kluger, D. M., & Crnich, C. J. (2006). The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings, 81(9), 1159-1171. https://doi.org/10.4065/81.9.1159
  16. Mitchell, M. D., Anderson, B. J., Williams, K., & Umscheid, C. A. (2009). Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journal of Advanced Nursing, 65(10), 2007-2021. https://doi.org/10.1111/j.1365-2648.2009.05103.x
  17. Odabas, H., Ozdemir, N. Y., Ziraman, I., Aksoy, S., Abali, H., Oksuzoglu, B., et al. (2013). Effect of port-care frequency on venous port catheter-related complications in cancer patients. International Journal of Clinical Oncology, 27. http://dx.doi.org/10.1007/s10147-013 -0609-7
  18. Vescia, S., Baumgartner, A. K., Jacobs, V. R., Kiechle-Bahat, M., Rody, A., Loibl, S., et al. (2008). Management of venous port systems in oncology: a review of current evidence. Annals of Oncology, 19(1), 9-15.

Cited by

  1. A Prospective Study of Extending the Implanted Port Heparin Flushing Cycle in Outpatients with Solid Tumors vol.30, pp.2, 2018, https://doi.org/10.7475/kjan.2018.30.2.216